ATE208186T1 - Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten - Google Patents

Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten

Info

Publication number
ATE208186T1
ATE208186T1 AT95931603T AT95931603T ATE208186T1 AT E208186 T1 ATE208186 T1 AT E208186T1 AT 95931603 T AT95931603 T AT 95931603T AT 95931603 T AT95931603 T AT 95931603T AT E208186 T1 ATE208186 T1 AT E208186T1
Authority
AT
Austria
Prior art keywords
drug delivery
cellulose ethers
geling
thermally
exhibits
Prior art date
Application number
AT95931603T
Other languages
English (en)
Inventor
Bhagwati P Kabra
John C Lang
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of ATE208186T1 publication Critical patent/ATE208186T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95931603T 1994-08-30 1995-08-23 Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten ATE208186T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29824494A 1994-08-30 1994-08-30
PCT/US1995/010877 WO1996006597A1 (en) 1994-08-30 1995-08-23 Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers

Publications (1)

Publication Number Publication Date
ATE208186T1 true ATE208186T1 (de) 2001-11-15

Family

ID=23149679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95931603T ATE208186T1 (de) 1994-08-30 1995-08-23 Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten

Country Status (14)

Country Link
US (1) US5618800A (de)
EP (1) EP0725628B1 (de)
JP (1) JPH09508143A (de)
CN (1) CN1162148C (de)
AT (1) ATE208186T1 (de)
AU (1) AU686455B2 (de)
CA (1) CA2172373C (de)
DE (1) DE69523733T2 (de)
DK (1) DK0725628T3 (de)
ES (1) ES2162638T3 (de)
MX (1) MX9601591A (de)
PT (1) PT725628E (de)
TW (1) TW460288B (de)
WO (1) WO1996006597A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19746264A1 (de) * 1997-10-20 1999-04-29 Wolff Walsrode Ag Verfahren zur Herstellung einer Carboxymethylcellulose mit verbesserter Wasserretention
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
CA2361421A1 (en) * 1999-02-03 2000-08-10 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
WO2000059947A1 (en) * 1999-04-01 2000-10-12 The Dow Chemical Company Enhanced gel strength methylcellulose
US6235893B1 (en) 1999-04-01 2001-05-22 The Dow Chemical Company Process for making cellulose ether having enhanced gel strength
US7226407B2 (en) 1999-06-09 2007-06-05 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US7121997B2 (en) 1999-06-09 2006-10-17 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US7083637B1 (en) 1999-06-09 2006-08-01 Tannhauser Robert J Method and apparatus for adjusting flexible areal polymer implants
US6932759B2 (en) 1999-06-09 2005-08-23 Gene W. Kammerer Surgical instrument and method for treating female urinary incontinence
PT1225898E (pt) 1999-11-01 2003-10-31 Alcon Inc Composicoes farmaceuticas contendo um farmaco antibiotico de fluoroquinolona e goma xantana
US7097855B1 (en) 2000-01-31 2006-08-29 Massachusetts Institute Of Technology Transdermal thermal polymerization
US7131943B2 (en) 2000-03-09 2006-11-07 Ethicon, Inc. Surgical instrument and method for treating organ prolapse conditions
PL199321B1 (pl) 2000-07-28 2008-09-30 Alcon Inc Kompozycje farmaceutyczne zawierające tobramycynę i gumę ksantanową
US20030060447A1 (en) * 2002-04-24 2003-03-27 Mutlu Karakelle Non-aspirating transitional viscoelastics for use in surgery
WO2002040056A2 (en) 2000-11-06 2002-05-23 Alcon, Inc Carrageenan viscoelastics for ocular surgery
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
ES2393426T3 (es) 2002-03-01 2012-12-21 Ethicon, Inc. Dispositivo para tratar prolapsos de órganos pélvicos en pacientes de sexo femenino
DE10224352A1 (de) * 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
US7727549B2 (en) * 2002-07-15 2010-06-01 Alcon, Inc. Pharmaceutical compositions for otic use
DE10350248A1 (de) * 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
US7527588B2 (en) 2004-09-15 2009-05-05 Ethicon, Inc. System and method for surgical implant placement
CA2586035A1 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
US7481314B2 (en) 2005-02-02 2009-01-27 Ethicon, Inc. Packaging assembly for surgical mesh implants
EP1909703A4 (de) 2005-08-04 2011-01-12 Bard Inc C R Systeme und verfahren für beckenimplantate
ES2470338T3 (es) 2005-11-14 2014-06-23 C.R. Bard, Inc. Sistema de anclaje de eslinga
US20070142478A1 (en) * 2005-12-21 2007-06-21 Erning Xia Combination antimicrobial composition and method of use
US20070140897A1 (en) * 2005-12-21 2007-06-21 Hongna Wang Ph stable biguanide composition and method of treatment and prevention of infections
US20070141091A1 (en) * 2005-12-21 2007-06-21 Erning Xia Biguanide ointment and method of treatment and prevention of infections
WO2008033950A2 (en) 2006-09-13 2008-03-20 C. R. Bard, Inc. Urethral support system
DE102006062140A1 (de) * 2006-12-22 2008-06-26 Dow Wolff Cellulosics Gmbh Celluloseetheradditive für die Extrusion keramischer Massen
US20080161405A1 (en) * 2006-12-29 2008-07-03 Erning Xia Biguanide Composition and Method of Treatment and Prevention of Infections
US8206280B2 (en) 2007-11-13 2012-06-26 C. R. Bard, Inc. Adjustable tissue support member
DE102007059939A1 (de) 2007-12-12 2009-06-18 Müller-Schulte, Detlef, Dr. Auflösbare, magnetische und unmagnetische Polymerträger zur Abtrennung und Wiedergewinnung von Zellen und Biosubstanzen
US8449573B2 (en) 2008-12-05 2013-05-28 Boston Scientific Scimed, Inc. Insertion device and method for delivery of a mesh carrier
US8968334B2 (en) 2009-04-17 2015-03-03 Boston Scientific Scimed, Inc. Apparatus for delivering and anchoring implantable medical devices
US9301750B2 (en) 2009-11-03 2016-04-05 Boston Scientific Scimed, Inc. Device and method for delivery of mesh-based devices
GB201105408D0 (en) 2011-03-30 2011-05-11 Glaxo Group Ltd Composition
US20160120990A1 (en) * 2013-07-17 2016-05-05 Dow Global Technologies Llc Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose
WO2015047762A1 (en) * 2013-09-25 2015-04-02 Dow Global Technologies Llc Composition for application to a mucosa comprising a cellulose ether
US20180071209A1 (en) * 2015-03-24 2018-03-15 Dow Global Technologies Llc Aqueous solution of polymers
CR20180128A (es) 2015-08-05 2018-04-24 Childrens Medical Center Composiciones con potenciadores de permeación para suministro de fármacos
CN109937033A (zh) * 2016-09-14 2019-06-25 儿童医学中心公司 用于药物递送的具有渗透增强剂的组合物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US3767788A (en) * 1970-06-08 1973-10-23 Burton Parsons Chemicals Inc Ophthalmic solution
SE403782B (sv) * 1973-03-14 1978-09-04 Mo Och Domsjoe Ab Nonjoniska cellulosaetrar
US4001211A (en) * 1974-12-02 1977-01-04 The Dow Chemical Company Pharmaceutical capsules from improved thermogelling methyl cellulose ethers
CS180191B1 (en) * 1974-12-04 1977-12-30 Arnost Kotik Tube shape heat exchanger with internal ribbing
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4136178A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3700681A1 (de) * 1987-01-12 1988-07-21 Breveteam Sa Sphaerisches faseraggregat, insbesondere als fuell- oder polstermaterial
US5279660A (en) * 1988-05-24 1994-01-18 Berol Nobel Stenungsund Ab Use of viscosity-adjusting agent to counteract viscosity decrease upon temperature increase of a water-based system
SE461396B (sv) * 1988-05-24 1990-02-12 Berol Kemi Ab Saett att vid temperaturhoejning motverka viskositetsnedgaang alternativt aastadkomma viskositetsoekning hos ett vattenbaserat system innehaallande en polymer som viskositetsgivare
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5306501A (en) * 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5077033A (en) * 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5124151A (en) * 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
SE9003712L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
US5212162A (en) * 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5296228A (en) * 1992-03-13 1994-03-22 Allergan, Inc. Compositions for controlled delivery of pharmaceutical compounds
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5470881A (en) * 1993-09-09 1995-11-28 West Virginia University Research Corporation Urea ophthalmic ointment and solution

Also Published As

Publication number Publication date
ES2162638T3 (es) 2002-01-01
CA2172373A1 (en) 1996-03-07
EP0725628A1 (de) 1996-08-14
DE69523733T2 (de) 2002-08-01
PT725628E (pt) 2002-03-28
DE69523733D1 (de) 2001-12-13
WO1996006597A1 (en) 1996-03-07
HK1012558A1 (en) 1999-08-06
AU3496595A (en) 1996-03-22
US5618800A (en) 1997-04-08
CN1134662A (zh) 1996-10-30
DK0725628T3 (da) 2001-12-27
AU686455B2 (en) 1998-02-05
EP0725628B1 (de) 2001-11-07
MX9601591A (es) 1997-05-31
JPH09508143A (ja) 1997-08-19
TW460288B (en) 2001-10-21
CN1162148C (zh) 2004-08-18
CA2172373C (en) 1999-03-16

Similar Documents

Publication Publication Date Title
ATE208186T1 (de) Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten
TWI262797B (en) Gelling ophthalmic compositions containing xanthan gum
MX9605678A (es) Produccion de composiciones de sustancia activa en forma de una solucion solida de la sustancia activa en una matriz de polimero, y composiciones de sustancia activa producidas por este procedimiento.
CA2230595A1 (en) Bioresorbable polymer use in cochlear and other implants
CA2338605A1 (en) Pliable and moldable polymeric delivery system for bioactive agents
DE69501463D1 (de) Rasiersystem
ES2184306T3 (es) Soluciones de acondicionamiento para el cuidado de las lentes de contacto duras.
DE69803940D1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
CA2173755A1 (en) Multi-functional inner ear treatment and diagnostic system
AU5242701A (en) Wound gels
ES2089930T3 (es) Gel acuoso de maquillaje con organopolisiloxano.
BR9910251A (pt) Estimulação hematopoiética
MX9203477A (es) Composicion bioactiva.
MX9803897A (es) Enzimas con puntos isoelectricos bajos para usarse en limpieza de lentes de contacto.
AU3223095A (en) Artificial tooth
EP0640647A3 (de) Ionisch vernetzte Gele aus Glykosaminoglykan zur Vermehrung von Weichgewebe und Arzneimittelabgabe.
CA2213719A1 (en) Transparent rapid-release preparation of non-steroid analgesics
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa
ATE240094T1 (de) Ophthalmische zusammensetzungen in form wässriger gele
ATE191845T1 (de) Pharmazeutische träger zur topischen ophthalmischen anwendung
AU646439B2 (en) Novel retinoids
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
ES2158267T3 (es) Colirio destinado especialmente al tratamiento de la sequedad de ojos.
ES8605906A1 (es) Un procedimiento para la preparacion de nuevos copolimeros estadisticos de vinil-pirrolidona.
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee